Menu Philippe 4

What Happened Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (SOPH), sold 7,393 shares on 2026-07-06 in open-market transactions. The filing reports a weighted-average price of $5.16 per share (range $4.97–$5.44), for total proceeds of approximately $38,156. This was a sale (routine cash outflow), not a purchase.

Key Details

• Transaction date: 2026-07-06; Form 4 filed: 2026-07-07 (appears timely).
• Reported price: weighted average $5.16; individual trades ranged $4.97–$5.44.
• Shares sold: 7,393; proceeds ≈ $38,156.
• Shares owned after transaction: Not disclosed in this filing.
• Footnotes: Sale executed pursuant to a pre-established Rule 10b5-1(c) trading plan and was done to satisfy tax withholding obligations arising from restricted stock units that vested on July 2 and July 3, 2026. The price shown is a weighted average; the filer can provide per-trade prices on request.

Context Sales to cover tax withholding on RSU vesting are common and are generally considered routine rather than a signal of changed insider sentiment. The transaction was executed under a 10b5-1 plan, meaning it was pre-scheduled and non-discretionary.